US Pharma MarketingExclusive: Brent Saunders
Rapalogix Health, co-founded by Brent Saunders, raises $20M Series A to advance mTOR skincare science and prep for a 2028 IND in esthetic dermatology. Topic Hubs AI drug discovery: News, analysis and interviews Antibody-drug conjugates: The next wave of targeted cancer drugs Biopharma M&A and dealmaking: Who’s buying and why Biopharma people moves: CEO changes, executive hires, board positions Biotech IPOs: Tracking the market for new public offerings Biotech venture funding: Who’s raising and where the money is going Cell and gene therapy manufacturing: Scaling the next frontier China biotech: Licensing deals and the Biosecure Act CRISPR and gene editing:…
Brent Saunders was thinking a lot about skincare and longevity during the Covid-19 pandemic, shortly after he finished up the more than $60 billion sale of Allergan to AbbVie.
After leaving the ...
Source: Endpoints News